Creo Medical Group PLC (GB:CREO)

Creo Medical (CREO) Share Price & Analysis


CREO Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range19.00p - 101.50p
Previous Close23.25p
Average Volume (3M)727.06K
Market Cap
Enterprise Value6.75B
Total Cash (Recent Filing)£26.10M
Total Debt (Recent Filing)£12.06M
Price to Earnings (P/E)-1.8
Sep 28, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding181,099,186
10 Day Avg. Volume64,541
30 Day Avg. Volume727,062
Standard Deviation0.19
Financial Highlights & Ratios
Price to Book (P/B)130.46
Price to Sales (P/S)2722.20
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside296.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1




What was Creo Medical Group PLC’s price range in the past 12 months?
Creo Medical Group PLC lowest share price was 19.00p and its highest was 101.50p in the past 12 months.
    What is Creo Medical Group PLC’s market cap?
    Currently, no data Available
    When is Creo Medical Group PLC’s upcoming earnings report date?
    Creo Medical Group PLC’s upcoming earnings report date is Sep 28, 2023 which is in 110 days.
      How were Creo Medical Group PLC’s earnings last quarter?
      Creo Medical Group PLC released its earnings results on Apr 26, 2023. The company reported -0.072p earnings per share for the quarter, missing the consensus estimate of N/A by -0.072p.
        Is Creo Medical Group PLC overvalued?
        According to Wall Street analysts Creo Medical Group PLC’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Creo Medical Group PLC pay dividends?
          Creo Medical Group PLC does not currently pay dividends.
          What is Creo Medical Group PLC’s EPS estimate?
          Creo Medical Group PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Creo Medical Group PLC have?
          Creo Medical Group PLC has 350,891,270 shares outstanding.
            What happened to Creo Medical Group PLC’s price movement after its last earnings report?
            Creo Medical Group PLC reported an EPS of -0.072p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.714%.
              Which hedge fund is a major shareholder of Creo Medical Group PLC?
              Currently, no hedge funds are holding shares in GB:CREO


              Creo Medical Stock Smart Score

              The Creo Medical Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Creo Medical Group PLC

              Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. Its reportable segments being the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.


              Forecast EPS vs Actual EPS

              Similar Stocks
              Price & Change
              Advanced Medical Solutions
              C4X Discovery Holdings
              Belluscura PLC
              Avacta Group plc

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis